Literature DB >> 16495197

Estimating the association between SF-12 responses and EQ-5D utility values by response mapping.

Alastair M Gray1, Oliver Rivero-Arias, Philip M Clarke.   

Abstract

BACKGROUND: Reliably mapping from generic or disease-specific health status measures into health state utilities would assist health economists. Existing studies mainly use ordinary least squares (OLS) regression equations to predict utility values for particular health states. The authors examine an alternative approach to map between 2 generic health status instruments, the SF-12 and the EQ-5D.
METHODS: Multinomial logit regression is used to estimate the probability that a respondent will select a particular level of response to questions in the EQ-5D, using individual question responses and summary scores from the SF-12 as predictors. Monte Carlo simulation methods are used to generate predicted EQ-5D responses, and utility scores (tariffs) are then attached. Results are compared with an alternative approach based on direct mapping to utility scores using OLS. DATA: The authors estimate equations using 12,967 adult survey responses-from the 2000 US Medical Expenditure Panel Survey. They report mean squared error (MSE) and mean absolute error (MAE) of their predicted utilities within this sample, and out-of-sample using 13,304 adults from the 1996 Health Survey for England.
RESULTS: The authors obtain an in-sample and out-of-sample MSE of 0.03, compared with 0.02 for the OLS approach. Their MAE of 0.11 is similar to OLS results. The authors' method predicts group mean utility scores and differentiates between groups with or without known existing illness.
CONCLUSIONS: The authors' approach has higher MSE than the direct OLS approach but gives more descriptive data on domains of health effects. Further out of sample prediction work will help test the validity of these methods.

Entities:  

Mesh:

Year:  2006        PMID: 16495197     DOI: 10.1177/0272989X05284108

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  89 in total

1.  Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.

Authors:  Mark Parker; Alan Haycox; Jane Graves
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

2.  Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.

Authors:  Mangala Rajan; Kuan-Chi Lai; Chin-Lin Tseng; Shirley Qian; Alfredo Selim; Lewis Kazis; Leonard Pogach; Anushua Sinha
Journal:  Qual Life Res       Date:  2012-03-06       Impact factor: 4.147

3.  Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from a measure of common mental health problems (CORE-OM).

Authors:  Ifigeneia Mavranezouli; John E Brazier; Tracey A Young; Michael Barkham
Journal:  Qual Life Res       Date:  2010-10-23       Impact factor: 4.147

4.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

5.  Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile Equating.

Authors:  Nicolas R Thompson; Brittany R Lapin; Irene L Katzan
Journal:  Pharmacoeconomics       Date:  2017-11       Impact factor: 4.981

6.  Association of health-related quality of life with health examination and lifestyles of government managers in China.

Authors:  Changrong Hou; Bin Lü; Zuxun Lu; Shilong Qin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-06

7.  How consistent are health utility values?

Authors:  Pedro L Ferreira; Lara N Ferreira; Luis N Pereira
Journal:  Qual Life Res       Date:  2008-08-08       Impact factor: 4.147

8.  Health-related quality of life associated with systemic corticosteroids.

Authors:  Patrick W Sullivan; Vahram H Ghushchyan; Gary Globe; Brandon Sucher
Journal:  Qual Life Res       Date:  2016-10-18       Impact factor: 4.147

9.  Quality-of-life loss of people admitted to burn centers, United States.

Authors:  Ted Miller; Soma Bhattacharya; William Zamula; Dennis Lezotte; Karen Kowalske; David Herndon; James Fauerbach; Loren Engrav
Journal:  Qual Life Res       Date:  2012-12-08       Impact factor: 4.147

10.  Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).

Authors:  X Badia; M Roset; E Valassi; H Franz; A Forsythe; S M Webb
Journal:  Qual Life Res       Date:  2013-03-29       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.